Similar Posts
Drugs Are Outrageously Expensive—Canada Found A Way To Fight Back
Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.
Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.
Why these enormous price differences?
When Less is More
Here is a news article discussing a paper I wrote with Michael Volk, in which we try to find ways to keep doctors from harming patients by finding and then getting all worked up over what we in medicine call incidentalomas–unexpected and ultimately benign findings that show up with unnecessary tests. The article is in the Archives of Internal Medicine this week.
